<DOC>
	<DOCNO>NCT01611766</DOCNO>
	<brief_summary>The purpose study evaluate role secondary cytoreduction ( SCR ) validate risk model patient selection criterion platinum-sensitive recurrent ovarian cancer .</brief_summary>
	<brief_title>Surgery Chemotherapy Recurrent Ovarian Cancer ( SOC 1 Trial ) ?</brief_title>
	<detailed_description>The primary objective study compare overall survival ( OS ) patient platinum-sensitive recurrent ovarian cancer positive SCR score randomize secondary cytoreductive surgery follow chemotherapy versus chemotherapy alone .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<criteria>Age recurrence â‰¥ 18 year Patients platinumsensitive , first relapse epithelial ovarian , primary peritoneal , fallopian tube cancer ( EOC , PPC , FTC ) , define treatment free interval 6 month . A complete secondary cytoreduction predict score , iMODEL [ Tian WJ , Ann Surg Oncol 2012,19 ( 2 ) :597604 ] &lt; =4.7 , include FIGO stage ( 0 0.8 ) ; residual disease primary surgery ( 0 1.5 ) ; Progressionfree interval ( 0 2.4 ) ; PS ECOG ( 0 2.4 ) ; Ca125 ( 0 1.8 ) ; ascites recurrence ( 0 3.0 ) . Assessed experienced surgeon , complete resection recurrent disease possible . If single lesion outside peritoneal cavity resect , MRI/CT PET/CT scan perform exclude simultaneous intraabdominal lesion . Patients give sign write informed consent consent . Patients borderline tumor well nonepithelial tumor . Patients intervaldebulking , secondlook surgery , palliative surgery plan . Impossible assess resectability evaluate score . Radiological sign suggest complete resection impossible . More one prior chemotherapy . Second relapse Patients second malignancy treat surgery , treatment might interfere treatment relapsed ovarian cancer major impact prognosis expect . Progression chemotherapy recurrence within 6 month firstline therapy Any contradiction allow surgery and/or chemotherapy 1 . Accompanied hypoxia serious chronic obstructive pulmonary disease 2 . Uncontrolled hypertension , cerebrovascular accident/ Stroke , myocardial infarct , unstable angina , untreated thrombosis , chronic congestive heart failure , serious arrhythmia need medicine . 3 . Severe hepatitis , history liver disease , nephrotic syndrome , renal insufficiency 4 . Active ulcer history , abdominal wall fistula , perforation gastrointestinal tract , Intraabdominal abscess , simultaneously apply treatment/prevent ulcer therapy . 5 . Uncontrolled diabetes 6 . Uncontrolled epilepsy need longterm antiepileptic treatment . Any medication induce considerable risk surgery , e.g . estimate bleed due oral anticoagulating agent , bevacizumab )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>secondary cytoreductive surgery</keyword>
	<keyword>Ovarian Cancer</keyword>
	<keyword>surgery</keyword>
	<keyword>recurrence</keyword>
</DOC>